Paul Ford - CEO
Specialty Drugs, Coronavirus, & the Opportunity to Reduce Cost
The promise of a miracle drug to combat Corvid-19 like Hydroxychloroquine has created polarizing perspectives on the optimism of...
top of page
Paul Ford - CEO
Mar 25, 20201 min
Podcast: OrchestraRx On "Reconstructing Healthcare"
In this episode, Michael Menerey, host of the Reconstructing Healthcare podcast chats with Paul Ford, the Founder, and CEO of...
Paul Ford - CEO
Mar 23, 20203 min
To Exclude or Not to Exclude?
Excluding drugs from your formulary can save you money, but so can not excluding drugs. In working with Taft-Hartley Union Trust,...
Paul Ford - CEO
Mar 23, 20204 min
Impact of Corvid-19 on Corporate Benefits: The Uphill Battle Just Got Steeper
Learn about the 3 impacts to corporate benefits in the CORVID-19 age.
bottom of page